CVS Health Payor Solutions
Payor Solutions
Main menu
Biosimilars
About
Our Story
Who We Serve
Integrated Assets
Insights
All Insights
Care Management
Cost Management
Drug Pipeline
GLP-1s
Government Programs & Services
Health Equity
Innovation
Public Policy
Specialty
Women's Health
Contributors
Programs & Services
Overview
Cost Management
Formulary Management
Network Strategies
Hyperinflation
Gene Therapy Solutions
Member Affordability
Specialty Management
Specialty Cost Management
Medical Benefit Solutions
Transform Oncology Care
Patient Care
Radiation Oncology
Care Management
Member Engagement
Onboarding
Benefit Plan Changes
Health Plan Client Engagement
Shortcuts
Contact Us
Resources
Videos
News
Webinars
Events
Other Sites
Client Care Access
CVS Health
CVS Caremark
CVS Specialty
CVS Pharmacy
CVS MinuteClinic
Search form
Search
Insights provides context and perspective about key pharmacy trends and issues
Format
All Formats
Briefing
Commentary
Feature
Infographic
Specialty Report
Video
White Paper
Insights Topic (field_insights_topic)
Care Management
Cost Management
Drug Pipeline
Government Programs and Services
Health Equity
Innovation
Public Policy
Specialty
Women's Health
Sort by
Most Recent
Most Popular
Insights Topic (field_insights_topic)
- Any -
Care Management
Cost Management
Drug Pipeline
Government Programs and Services
Health Equity
Innovation
Public Policy
Specialty
Women's Health
Drug Pipeline
Getting personal with mRNA cancer vaccines
Getting personal with mRNA vaccines for cancer
More
Briefing
Drug Pipeline
Protecting Infants and Young Children from RSV
Protecting Infants and Young Children from RSV
More
Briefing
Drug Pipeline
Non-Alcoholic Steatohepatitis on the Rise Around the World
Non-Alcoholic Steatohepatitis on the Rise Around the World
More
Briefing
Insights
offers context and perspective about key pharmacy and health care topics.
Subscribe
Drug Pipeline
Promising Treatments for Alopecia Areata in the Pipeline
New Treatments for Alopecia Areata on the Horizon
More
Briefing
Drug Pipeline
What's Next for Hemophilia Treatments?
What's Next for Hemophilia Therapy and New Treatment Options?
More
Briefing
Drug Pipeline
Keeping an Eye on the Drug Pipeline
New Drugs for Ophthalmic Disorders on the Horizon
More
Briefing
Drug Pipeline
Anticipating a Breakthrough Therapy for Type 1 Diabetes
Teplizumab: Potential Breakthrough Therapy for Type 1 Diabetes
More
Briefing
Drug Pipeline
A Q2 2022 Look at Projected Gene Therapies and Approval Timelines
A Q2 2022 Look at Projected Gene Therapies and FDA Approval Timelines
More
Briefing
Drug Pipeline
Treatment Options Expand in Robust Gene Therapy Pipeline
New Gene Therapies for Sickle Cell Disease, Hemophilia on the Horizon
More
Briefing
Drug Pipeline
More Treatments, Costs for Patients with Inflammatory Bowel Disease
As more treatments for inflammatory bowel disease are approved, payors can counter cost increases with comprehensive utilization management.
More
Briefing
Drug Pipeline
Expanding Therapies, Indications and Implications for Payors
2022 Marketplace Outlook: Expanding Therapies, Indications and Implications for Payors
More
Briefing
Drug Pipeline
Breakthrough Therapies and New Biologics Feature in the Gene Therapy Pipeline
Breakthrough Therapies and New Biologics Feature in the Gene Therapy Pipeline
More
Briefing
Drug Pipeline
Speciality Pharmacy Pipeline Drugs to Watch | Q4 2021 - Q1 2022
Key drugs to watch for in the specialty pharmacy pipeline Q4 2021 - Q1 2022
More
Specialty Report
Load more